Suchergebnisse - "Zhong, Xiaorong"

PubPharm (122)

1

HER2-low heterogeneity between primary and paired recurrent/metastatic breast cancer : Implications in treatment and prognosis

enthalten in: Cancer | 2024

von Lin, M. | Luo, T. | Jin, Y. | +9

2

Cost-Effectiveness Analysis of Adjuvant Endocrine Therapy With Ovarian Suppression in Premenopausal Patients With Hormone Receptor-Positive Early Breast Cancer in China

enthalten in: Clinical breast cancer | 2024

von Zhong, X. | Chen, P. | He, P. | +7

3

HER2-targeted therapies in cancer : a systematic review

enthalten in: Biomarker research | 2024

von Zhu, K. | Yang, X. | Tai, H. | +3

4

HER2-targeted therapies in cancer: a systematic review

enthalten in: Biomarker Research | 2024

von Zhu, K. | Yang, X. | Tai, H. | +3

5

DDX58 deficiency leads to triple negative breast cancer chemotherapy resistance by inhibiting Type I IFN-mediated signalling apoptosis

enthalten in: Frontiers in oncology | 2024

von Cao, S. | Long, X. | Xiao, L. | +7

6

miR-942-5p Regulates Proliferation, Invasion and EMT of Trophoblast Cells in Gestational Diabetes by Targeting the CEBPA

enthalten in: Alternative therapies in health and medicine | 2024

von Chu, Q. | Zhong, X. | Lu, Y. | +1

7

HER2‐low heterogeneity between primary and paired recurrent/metastatic breast cancer : Implications in treatment and prognosis

enthalten in: Cancer | 2024

von Lin, M. | Luo, T. | Jin, Y. | +9

8

Silencing HE4 alleviates the renal fibrosis in lupus nephritis mice by regulating the C3/MMPs/prss axis

enthalten in: Naunyn-Schmiedeberg's archives of pharmacology | 2023

von Li, Y. | Zhong, X. | Yang, F.

9

Efficacy and safety of tucidinostat in patients with advanced hormone receptor-positive human epidermal growth factor receptor 2-negative breast cancer : real-world insights

enthalten in: Annals of translational medicine | 2023

von Suo, J. | Zhu, K. | Zhuang, C. | +6

10

Pyrotinib and chrysin synergistically potentiate autophagy in HER2-positive breast cancer

enthalten in: Signal transduction and targeted therapy | 2023

von Liu, X. | Zhang, X. | Shao, Z. | +10

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]